Trademark: 88368976
Word
IVIG IS OUR MIDDLE NAME
Status
Dead
Status Code
606
Status Date
Monday, April 10, 2023
Serial Number
88368976
Mark Type
4000
Filing Date
Wednesday, April 3, 2019
Published for Opposition
Tuesday, January 14, 2020
Abandoned Date
Monday, April 10, 2023

Trademark Owner History
CSL Behring AG - Owner At Publication

Classifications
41 Healthcare education services, namely, conducting educational programs for patients, caregivers and/or healthcare professionals concerning immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; planning and conducting educational conventions and educational meetings related to immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals
16 Printed materials, namely, newsletters, articles and case studies featuring immunoglobulin, immunodeficiency and neurological disorders; Printed publications, namely, brochures, booklets, newsletters, articles, case studies, and teaching materials in the field of immunoglobulin, immunodeficiency and neurological disorders; printed educational materials in the field of immunoglobulin, immunodeficiency and neurological disorders
35 Healthcare education services, namely, promoting awareness of immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals to patients, caregivers and/or healthcare professionals
44 Providing a website featuring information in the field of immunoglobulin, immunodeficiency and neurological disorders, and corresponding treatments; Healthcare and healthcare information services, namely, providing information concerning immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals; Healthcare and healthcare information services, namely, providing information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by immunoglobulin, immunodeficiency and neurological disorders; Providing a website featuring information in the field of the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders; Providing links to the web sites of others featuring information about the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders
INTRAVENOUS IMMUNOGLOBULIN IS OUR MIDDLE NAME
"IVIG"

Trademark Events
Apr 10, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 10, 2023
Abandonment - No Use Statement Filed
Aug 20, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 19, 2022
Sou Extension 5 Granted
Aug 10, 2022
Sou Extension 5 Filed
Aug 19, 2022
Case Assigned To Intent To Use Paralegal
Aug 10, 2022
Teas Extension Received
Feb 12, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 10, 2022
Sou Extension 4 Granted
Feb 10, 2022
Sou Extension 4 Filed
Feb 10, 2022
Teas Extension Received
Aug 12, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 10, 2021
Sou Extension 3 Granted
Aug 10, 2021
Sou Extension 3 Filed
Aug 10, 2021
Teas Extension Received
Feb 12, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 10, 2021
Sou Extension 2 Granted
Feb 10, 2021
Sou Extension 2 Filed
Feb 10, 2021
Teas Extension Received
Aug 12, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 10, 2020
Sou Extension 1 Granted
Aug 10, 2020
Sou Extension 1 Filed
Aug 10, 2020
Teas Extension Received
Mar 10, 2020
Noa E-Mailed - Sou Required From Applicant
Jan 14, 2020
Official Gazette Publication Confirmation E-Mailed
Jan 14, 2020
Published For Opposition
Dec 25, 2019
Notification Of Notice Of Publication E-Mailed
Dec 10, 2019
Approved For Pub - Principal Register
Dec 9, 2019
Teas/Email Correspondence Entered
Dec 9, 2019
Correspondence Received In Law Office
Dec 9, 2019
Teas Response To Office Action Received
Jun 20, 2019
Notification Of Examiner's Amendment/Priority Action E-Mailed
Jun 20, 2019
Examiner's Amendment/Priority Action E-Mailed
Jun 20, 2019
Combined Examiner's Amendment/Priority Action Automatic Entry
Jun 20, 2019
Examiners Amendment And/Or Priority Action - Completed
Jun 12, 2019
Assigned To Examiner
Apr 20, 2019
New Application Office Supplied Data Entered
Apr 6, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24